Bildkälla: Stockfoto

Annexin: Our Q2 Comment - Redeye

Redeye comments on today’s Q2 report from Annexin Pharmaceuticals and largely reiterate our view of the company.

Redeye comments on today’s Q2 report from Annexin Pharmaceuticals and largely reiterate our view of the company.
Börsvärldens nyhetsbrev
ANNONSER